Publication

SARS-CoV-2-host proteome interactions for antiviral drug discovery.

Liu X, Huuskonen S, Laitinen T, Redchuk T, Bogacheva M, Salokas K, Poehner I, Oehman T, Tonduru AK, Hassinen A, Gawriyski L, Keskitalo S, Vartiainen MK, Pietiaeinen V, Poso A, Varjosalo M

Treatment options for COVID-19, caused by SARS-CoV-2, remain limited. Understanding viral pathogenesis at the molecular level is critical to develop effective therapy. Some recent studies have explored SARS-CoV-2-host interactomes and provided great resources for understanding viral replication. However, host proteins that functionally associate with SARS-CoV-2 are localized in the corresponding subnetwork within the comprehensive human interactome. Therefore, constructing a downstream ... [more]

Quantitative Score

• 0.98 [Saint Score]

Throughput

• High Throughput

Additional Notes

• High confidence interactions are assigned based on their statistical filtering score (BFDR =< 0.01) and further refined using the CRAPome contaminant repository.
• The associated score is the original published SAINT score determined by the authors using Significance Analysis of INTeractome (SAINT) express version 3.6.0.

Related interactions

Curated By

• BioGRID